Cracking the code for organ-specific drug delivery
Peer-Reviewed Publication
Updates every hour. Last Updated: 12-Jan-2026 01:11 ET (12-Jan-2026 06:11 GMT/UTC)
Researchers at the National Institutes of Health (NIH) have shown for the first time that a type of human papillomavirus (HPV) commonly found on the skin can directly cause a form of skin cancer called cutaneous squamous cell carcinoma (cSCC) when certain immune cells malfunction. cSCC is one of the most common cancers in the United States and worldwide. Previously, scientists believed HPV merely facilitated the accumulation of DNA mutations caused by ultraviolet (UV) radiation, usually the primary driver of cSCC. The findings were published today in The New England Journal of Medicine.
In low-resource settings, babies born with gastroschisis — a congenital condition in which the developing intestines extend outside the body through a hole in the abdominal wall —face life-threatening challenges. While survival rates in high-income countries now exceed 90% thanks to advanced medical tools and neonatal care, infants in resource-constrained medical settings still face high mortality rates, partially because of a lack of access to the lifesaving equipment needed to treat the condition. A team of engineers and pediatric surgeons led by Rice University’s Rice360 Institute for Global Health Technologies is working to change that. Their innovation? A simple, low-cost and locally manufacturable medical device, known as the “SimpleSilo,” designed to provide lifesaving treatment for gastroschisis at a fraction of the current cost and made from locally available materials.
When a cheeseburger costs less than a punnet of strawberries, it’s clear the odds are stacked against healthy choices – especially for teenagers. Now, new research from the University of South Australia shows that it’s not just unhealthy eating habits affecting teens, but an alarming clustering of poor lifestyle choices that’s putting the majority of teenagers at serious risk of preventable diseases later in life.
In a paper published in MedComm – Future Medicine, a Chinese research team presents ImmunoCheckDB, a comprehensive web platform integrating meta-analysis and multiomic data to discover cancer immunotherapy biomarkers. The platform curates 173 studies on immune checkpoint inhibitor (ICI) therapies, covering survival outcomes for 93,234 individuals across 18 cancer types and 30 ICI regimens, enabling pan-cancer exploration of molecular markers for ICI efficacy.